Prada restarts production with high safety protocol

 

As set out in the internal safety protocol signed by the company, employee health and safety representatives, the medical coordinator and the health and safety service, the measures involve reduced hours, or hours split up over multiple shifts, to ensure staggered access to the sites and the correct distancing of approximately two metres between workstations. 

 

In addition, the Prada Group is the first Italian company to introduce a cutting-edge safety protocol that involves the double screening of employees, in a collaboration already agreed with Careggi hospital in Florence. This procedure will be applied at the Tuscan sites that are currently operational, and will later be extended to all premises in the other Italian regions. 

 

Moreover, the group has signed commercial agreements with Menarini Diagnostics to supply the testing kits for the serological test, and with a world leading company in the molecular diagnostics sector to supply reagent testing kits to hospitals. With the aim of not depleting the public health system’s stocks, these materials will be bought directly from the above mentioned suppliers. 

 

“In this emergency situation we have not only been considering when to reopen our manufacturing facilities, but above all how to reopen them in total security, in order to safeguard our employees’ health and protect them from the virus. We therefore immediately sought advice from leading healthcare facilities and from specialist pharmaceutical companies to identify the top-rated medical technology currently available to safeguard the health of our employees with these virus-screening procedures and to contain the virus," Patrizio Bertelli, Prada Group’s CEO, said in a press release.

 

The introduction of these measures means we can now confidently restart production in Tuscany, and look forward to extending the above protocols to our plants and offices in other regions, when they reopen.”